The reality facing the generic pharmaceutical industry today is a continuous decline towards a purely commodity-based business, creating tremendous pressures on operating costs. This provides both challenges and opportunities for Alvogen. The future of a successful generic pharmaceuticals company rests on creating a lean, flexible, multinational operation that overcomes the challenges of the traditional generic business model. History has taught us that challenging times create real opportunities for change – new ideas and new approaches.
We are rethinking generics, with a radical new business model that creates the pharmaceutical company of tomorrow. Our employees have an inherent thirst for change that is clearly visible in our business model, processes and actions. Like athletes, inventors and explorers before us, we know that there can always be a better way to do things, if only we dare to challenge the status quo and rethink the future. Alvogen aims to build a top-10 global generics player.